The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit professionals involved in working ...
A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...
(Office of the Special Narcotics Prosecutor in New York via AP) A recreational drug called “pink cocaine” is getting attention and causing confusion since it doesn’t typically contain cocaine. The ...
Allergan Aesthetics, an AbbVie company, announced the US FDA approval of Botox Cosmetic for temporary ... with the appearance of their neck and jawline definition 14 days after treatment with a dose ...
Hem Securities Ltd. is the book-running lead manager of the issue and Hem Finlease is the market maker. The grey market premium (GMP) on the Danish Power IPO was Rs 265 as of 8:28 p.m. on Oct. 22, ...
Hyundai Motor India's shares currently trading at a discount to the issue price of Rs 1,960. The grey market premium (GMP) stands at Rs 1,903, reflecting a -3% premium. If trends persist, the stock is ...
Hyundai Motor India shares are showing a weak trend in the unlisted market as the grey market premium (GMP) has dried. According to stock market experts, Hyundai IPO GMP today is ₹-33.
A further search of his home then revealed drug paraphernalia and a GMP property bag containing traces of cocaine. Talbot refused to hand over the pin number for his mobile phone. However ...
The grey market premium (GMP) of unlisted shares of Hyundai Motor India has taken a hit and fallen below 1 per cent (0.87 per cent), reflecting subdued market sentiments for the initial public ...
17:32 (IST) 18 Oct 2024 Hyundai Motor India IPO Live Updates: Hyundai Motor India IPO touches lowest GMP price The Hyundai Motor India IPO touched the lowest GMP price Rs -57 on October 18 ...
According to Rule 122 E of the Drug and Cosmetic Rules 1945 ... view of this it was proposed to include all antibiotics in the definition of “new drug’’ in New Drugs and Clinical Trial ...